Skip to content

Clinical trials

Metabolic Diseases trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Country / region: Singapore Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20142
20152
20171
20181
20192
20213
20221
20244
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting5
Active, not recruiting4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
KK Women's and Children's Hospital7
Singapore Institute of Food and Biotechnology Innovation4
89bio, Inc.2
Kastle Therapeutics, LLC2
Intellia Therapeutics1
National University Health System, Singapore1
National University Hospital, Singapore1
Novartis Pharmaceuticals1
Singapore General Hospital1
Tan Tock Seng Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases21
Diabetes, Gestational4
Diabetes Mellitus3
Genetic Diseases, Inborn3
Metabolism, Inborn Errors3
Obesity3
Cardiovascular Diseases2
Congenital Abnormalities2
Developmental Origins of Health and Disease2
Diabetes Mellitus, Type 22

Trials

Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.